Roberto Beteta-Göbel

Statistics

Publications

Citations

113

H-Index

Active since

2015

Affiliations

Universitat de les Illes Balears(Current)

Roberto Beteta-Göbel is an author at Universitat de les Illes Balears specializing in oncology, pharmacology, and cancer cell proliferation inhibition.

ORCID

Publications per year

2015–2021

Publications

The Novel Antitumor Compound HCA Promotes Glioma Cell Death by Inducing Endoplasmic Reticulum Stress and Autophagy

Roberto Beteta-Göbel, Javier Fernández-Díaz, Laura Arbona-González et al. · Cancers · 2021 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17

The Opposing Contribution of SMS1 and SMS2 to Glioma Progression and Their Value in the Therapeutic Response to 2OHOA

Paula Fernández‐García, Catalina Ana Rosselló, Raquel Rodríguez-Lorca et al. · Cancers · 2019 · 31 citations · Full text

Medicine, Oncology, Pharmacology +16

The triacylglycerol, hydroxytriolein, inhibits triple negative mammary breast cancer cell proliferation through a mechanism dependent on dihydroceramide and Akt

Francisca Guardiola-Serrano, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca et al. · Oncotarget · 2019 · 20 citations · Full text

Life Sciences, Oncology, Pharmacology +17

The Novel Anticancer Drug Hydroxytriolein Inhibits Lung Cancer Cell Proliferation via a Protein Kinase Cα– and Extracellular Signal-Regulated Kinase 1/2–Dependent Mechanism

Francisca Guardiola-Serrano, Roberto Beteta-Göbel, Raquel Rodríguez-Lorca et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 17 citations

Medicine, Oncology, Pharmacology +16

1–4 of 4